金币
UID24640
帖子
主题
积分18504
注册时间2012-3-30
最后登录1970-1-1
听众
性别保密
|
欢迎您注册蒲公英
您需要 登录 才可以下载或查看，没有帐号？立即注册
x
MHRA布发OOS指南幻灯片。只有编辑上的变化, 如ppt格式。这对培训的使用很方便。
The MHRA first published guidance to industry on how to handle OOS investigations in August 2013. When the guidance was first released there was some what of a mixed reaction. Mainly because the guidance is in the form of a flow chart, so it didn’t look like other guidance and there was next to no focus on how much repeat testing is enough. Up until that point the main approach to handling out of specification results was to repeat the testing a further two times and hope for 2 results that pass. This logic is flawed and definitely not based on sound scientific rational. The good news is that since the publication of the guidance those involved in conducting investigations have with mixed success, embraced the concept of hypothesis testing. Despite this being a signification shift in the right direction, there is still a way to go. When a laboratory embarks on an investigation their biggest challenge is to move from a position of “I think this is the cause” to “I know this is the cause”. It was this challenge that gave rise to the idea for the presentations delivered in the GMP stream at the recent MHRA Labs Symposium.
How to inspect Laboratories was also the theme at the September 2017 PICS training event for inspectors. This event provided another opportunity on a global level to discuss the guidance and share how best it could be used.
The guidance offers a stepwise approach on what should be considered at the each stage of the investigation. It has recently been reviewed and apart from some minor changes, mainly to do with ease of use, it is much the same.
|
|
|手机版|蒲公英|ouryao|蒲公英
( 京ICP备14042168号-1 ) 增值电信业务经营许可证编号：京B2-20243455 互联网药品信息服务资格证书编号：(京)-非经营性-2024-0033
发表于 2018-3-3 09:46:49
置顶卡
变色卡
